Form 8-K - Current report:
SEC Accession No. 0001437749-25-037910
Filing Date
2025-12-16
Accepted
2025-12-16 08:00:11
Documents
14
Period of Report
2025-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20251216_8k.htm   iXBRL 8-K 23787
2 EXHIBIT 99.1 ex_899241.htm EX-99.1 21872
  Complete submission text file 0001437749-25-037910.txt   182300

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20251216.xsd EX-101.SCH 3580
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20251216_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20251216_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20251216_pre.xml EX-101.PRE 11585
16 EXTRACTED XBRL INSTANCE DOCUMENT bcda20251216_8k_htm.xml XML 2824
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 251573372
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)